Returns On Capital Are Showing Encouraging Signs At Ningbo Sanxing Medical ElectricLtd (SHSE:601567)
Returns On Capital Are Showing Encouraging Signs At Ningbo Sanxing Medical ElectricLtd (SHSE:601567)
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. So when we looked at Ningbo Sanxing Medical ElectricLtd (SHSE:601567) and its trend of ROCE, we really liked what we saw.
如果我們想找到潛在的多袋裝貨商,通常有潛在的趨勢可以提供線索。在一個完美的世界中,我們希望看到一家公司向其業務投入更多資本,理想情況下,從這些資本中獲得的回報也在增加。基本上,這意味着公司擁有可以繼續進行再投資的盈利計劃,這是複合機器的特徵。因此,當我們查看寧波三星醫療電氣有限公司(SHSE: 601567)及其投資回報率的趨勢時,我們真的很喜歡我們所看到的。
What Is Return On Capital Employed (ROCE)?
什麼是資本使用回報率(ROCE)?
Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. Analysts use this formula to calculate it for Ningbo Sanxing Medical ElectricLtd:
爲了澄清一下你是否不確定,ROCE是評估公司從投資於其業務的資本中獲得多少稅前收入(按百分比計算)的指標。分析師使用這個公式來計算寧波三星醫療電氣有限公司的值:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
已動用資本回報率 = 息稅前收益 (EBIT) ¥(總資產-流動負債)
0.13 = CN¥1.6b ÷ (CN¥18b - CN¥5.8b) (Based on the trailing twelve months to September 2023).
0.13 = 16億元人民幣 ÷(18億元人民幣-5.8億元人民幣) (基於截至2023年9月的過去十二個月)。
Therefore, Ningbo Sanxing Medical ElectricLtd has an ROCE of 13%. On its own, that's a standard return, however it's much better than the 6.3% generated by the Electrical industry.
因此,寧波三星醫療電氣有限公司的投資回報率爲13%。就其本身而言,這是標準回報,但要比電氣行業產生的6.3%好得多。
![roce](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240221/0-3ef3477fa8acd44846a38090f7bd8847-0-1f7b34d3bb7b48d352cb747a4524acf9.png/big)
In the above chart we have measured Ningbo Sanxing Medical ElectricLtd's prior ROCE against its prior performance, but the future is arguably more important. If you're interested, you can view the analysts predictions in our free analyst report for Ningbo Sanxing Medical ElectricLtd .
在上圖中,我們將寧波三星醫療電氣有限公司之前的投資回報率與之前的業績進行了對比,但可以說,未來更爲重要。如果您有興趣,可以在我們爲寧波三星醫療電氣有限公司提供的免費分析師報告中查看分析師的預測。
So How Is Ningbo Sanxing Medical ElectricLtd's ROCE Trending?
那麼,寧波三星醫療電氣有限公司的投資回報率走勢如何?
Investors would be pleased with what's happening at Ningbo Sanxing Medical ElectricLtd. Over the last five years, returns on capital employed have risen substantially to 13%. The company is effectively making more money per dollar of capital used, and it's worth noting that the amount of capital has increased too, by 21%. This can indicate that there's plenty of opportunities to invest capital internally and at ever higher rates, a combination that's common among multi-baggers.
投資者會對寧波三星醫療電氣有限公司發生的事情感到滿意。在過去五年中,已動用資本回報率大幅上升至13%。實際上,該公司每使用1美元資本就能賺更多的錢,值得注意的是,資本金額也增加了21%。這可能表明,內部有很多機會以更高的利率進行資本投資,這種組合在多袋公司中很常見。
The Key Takeaway
關鍵要點
A company that is growing its returns on capital and can consistently reinvest in itself is a highly sought after trait, and that's what Ningbo Sanxing Medical ElectricLtd has. And with the stock having performed exceptionally well over the last five years, these patterns are being accounted for by investors. With that being said, we still think the promising fundamentals mean the company deserves some further due diligence.
一家資本回報率不斷提高且能夠持續進行自我再投資的公司是一個備受追捧的特徵,而這正是寧波三星醫療電氣有限公司所擁有的。而且,由於該股在過去五年中表現異常出色,投資者正在考慮這些模式。話雖如此,我們仍然認爲前景良好的基本面意味着公司值得進一步的盡職調查。
On a separate note, we've found 1 warning sign for Ningbo Sanxing Medical ElectricLtd you'll probably want to know about.
另一方面,我們發現了你可能想知道的寧波三星醫療電氣有限公司的1個警告標誌。
For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity.
對於那些喜歡投資穩健公司的人,可以查看這份資產負債表穩健和股本回報率高的公司的免費清單。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。